Polygeline

From WikiProjectMed
(Redirected from Haemaccel)
Jump to navigation Jump to search
Polygeline
Names
Trade namesHaemaccel[1]
Other namesProcessed bovine gelatin
Clinical data
Drug classPlasma expander
Main usesHypovolemic shock[1][2]
Side effectsAnaphylaxis[1][2]

Polygeline, sold under the brand name Haemaccel among others, is a type of intravenous colloid used to treat hypovolemic shock.[1][2] This includes cases due to bleeding, fluid loss, and pancreatitis.[2][3] It is given by injection into a vein.[4]

Side effects may include anaphylaxis, with wheezing, low blood pressure, and hives; which occurs in about 0.8% of cases.[1][2][5] It does not alter cross matching of blood.[1] It may be used in people with kidney problems.[1] It is made from gelatin from cow bones.[1][2] It also contains sodium chloride, potassium chloride, and calcium chloride.[3]

Polygeline was first made in 1962 by Schmidt-Thome.[1] While used in Europe, it is not available in the United States.[6] It is on the World Health Organization's List of Essential Medicines as an alternative to dextran 70.[7] They are not very expensive as of 2005.[8]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 1.8 Srivastava, RP (December 2020). "Place of Polygeline in Fluid Resuscitation: Focus on Hypovolemic Shock". Indian J Surg. 82: 1229–1234. doi:10.1007/s12262-020-02221-y.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Kong, Fabian (2000). "Haemaccel (Polygeline) Reactions Anaphylaxis or Anaphylactoid?". The Australian Journal of Hospital Pharmacy. 30 (3). doi:10.1002/jppr2000303107. Archived from the original on 16 September 2023. Retrieved 13 September 2023.
  3. 3.0 3.1 "Haemaccel". EMC. Archived from the original on 16 September 2023. Retrieved 13 September 2023.
  4. "Polygeline". WHO. Archived from the original on 4 June 2023. Retrieved 13 September 2023.
  5. Barron, Michael (May 2004). "A systematic review of the comparative safety of colloids". Arch Surg. 139 (5): 552. doi:10.1001/archsurg.139.5.552. PMID 15136357.
  6. McNeil, E. L. (6 December 2012). Airborne Care of the Ill and Injured. Springer Science & Business Media. p. 138. ISBN 978-1-4684-8679-7. Archived from the original on 16 September 2023. Retrieved 13 September 2023.
  7. World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
  8. Lake, Carol L.; Booker, Peter D. (2005). Pediatric Cardiac Anesthesia. Lippincott Williams & Wilkins. p. 638. ISBN 978-0-7817-5175-9. Archived from the original on 16 September 2023. Retrieved 13 September 2023.

External links